Pfizer Reports Second-Quarter 2010 Results

Tuesday, August 3, 2010 Corporate News
Email Print This Page Comment
Font : A-A+

Full-Year 2012 Targets

($ billions, except per-share amounts)

Net Income(b)

Diluted EPS(b)

Income/(Expense)

Adjusted Income/Diluted EPS(1) Targets

~$18.3 - $19.1

~$2.25 - $2.35

Purchase Accounting Impacts of Transactions Completed as of 7/4/10

(3.8)

(0.47)

Acquisition-Related Costs

(1.2 – 1.6)

(0.15 – 0.20)

Reported Net Income Attributable to Pfizer Inc./Diluted EPS Targets

~$12.9 - $14.1

~$1.58 - $1.73

(a) The current exchange rates assumed in connection with the 2012 financial targets are the mid-July 2010 exchange rates.

(b)Given the longer-term nature of these targets, they are subject to greater variability and less certainty as a result of potential material impacts related to foreign exchange fluctuations, macroeconomic activity including inflation, and industry-specific challenges including changes to government healthcare policy, among others. 



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook